Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition

Cyclacel Pharmaceuticals, Inc. (CYCC) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 57,600 shares @ $0
02/02/2023 4 Kirschbaum Mark (Chief Medical Officer) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 31,200 shares @ $0
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Walker Karin L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
06/16/2022 4 Spiegel Robert J. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
06/16/2022 4 Sems Lloyd (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
06/16/2022 4 SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
06/16/2022 4 HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
06/16/2022 4 BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 15,822 shares @ $0
Granted 31,645 options to buy @ $1.11, valued at $35.1k
12/15/2021 4 Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 190,000 options to buy @ $3.45, valued at $655.5k
12/15/2021 4 McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $3.45, valued at $345k
12/15/2021 4 Kirschbaum Mark (Chief Medical Officer) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $3.45, valued at $345k
12/02/2021 4 BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Sold 12 shares @ $3.5716, valued at $42.9
11/22/2021 4 Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Bought 4,000 shares @ $4.5, valued at $18k
08/25/2021 4 BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Bought 1,000 shares @ $5, valued at $5k
06/17/2021 4 Hradsky Gregory T. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
06/17/2021 4 Sems Lloyd (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
06/17/2021 4 BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
06/17/2021 4 Spiegel Robert J. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
06/17/2021 4 HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
06/17/2021 4 SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 1,187 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
Granted 2,374 options to buy @ $6.69, valued at $15.9k
06/17/2021 4 Walker Karin L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 2,374 shares @ $0
Granted 1,187 shares @ $0
Granted 4,748 options to buy @ $6.69, valued at $31.8k
Granted 2,374 options to buy @ $6.69, valued at $15.9k
12/21/2020 4 SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 5,200 options to buy @ $4.13, valued at $21.5k
12/15/2020 4 McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.
Txns: Granted 120,000 options to buy @ $4.32, valued at $518.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy